Cancer Screening Rates and Outcomes for Justice-Involved Individuals: A Scoping Review
Journal of Correctional Health Care · 2023
DOI: 10.1089/jchc.21.11.0128 ↗Kurz gefasst
Scoping Review in der Zeitschrift Journal of Correctional Health Care, 2023. Verfasst von Christopher R Manz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Prisoners. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Individuals who have been incarcerated or under community supervision have elevated cancer mortality. This review summarizes existing knowledge on implementation and outcomes of cancer screening for justice-involved individuals to identify opportunities for reducing cancer disparities. This scoping review identified 16 studies published between January 1990 and June 2021 that reported cancer screening rates and outcomes in U.S. jails or prisons or for individuals under community supervision. Most studies evaluated cervical cancer screening, while fewer studies evaluated screening for breast, colon, prostate, lung, and hepatocellular cancers. Although incarcerated women are often up to date with cervical cancer screening, only about half had recent mammograms and only 20% of male patients were up to date with colorectal cancer screening. Justice-involved patients are at high risk of cancer, yet few studies have evaluated cancer screening for these populations and screening rates for many cancers appear low. The findings suggest that intensification of cancer screening for justice-involved populations may address cancer disparities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
- Harvard Medical School, Boston, Massachusetts, USA.
- Harvard University, Boston, Massachusetts, USA.
- Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
ORCID-Profile: Christopher R Manz
Förderung
- NCI NIH HHS
Zitieren
APA
Manz, C. R., Odayar, V. S., & Schrag, D. (2023). Cancer Screening Rates and Outcomes for Justice-Involved Individuals: A Scoping Review. Journal of Correctional Health Care. https://doi.org/10.1089/jchc.21.11.0128
Vancouver
Manz CR, Odayar VS, Schrag D. Cancer Screening Rates and Outcomes for Justice-Involved Individuals: A Scoping Review. Journal of Correctional Health Care. 2023. doi:10.1089/jchc.21.11.0128
BibTeX
@article{Manz2023,
author = {Manz, Christopher R and Odayar, Varshini S and Schrag, Deborah},
title = {Cancer Screening Rates and Outcomes for Justice-Involved Individuals: A Scoping Review},
journal = {Journal of Correctional Health Care},
year = {2023},
doi = {10.1089/jchc.21.11.0128}
}
EUVIMED